Consistent with previous studies, AS ameliorated cancer-associated inflammation, decreased the expression of inflammatory factors such as TGF-β and IL-10, and suppressed M2 macrophage polarization when administered to treat lung cancer [29]. Here, TGFB1 is linked to lung carcinoma.